Rainbow Rare Earths Phalaborwa project shaping up to be one of the lowest cost producers globally. Watch the video here.
In terms of what is needed to prove the efficacy, clinical claims, the claim of heating cooling, etc etc
It is the context of my reply to your post. It is not hard to follow.
Of course the consumer will be judge and jury and it works.
PS, I don't need to do anything you say.
The judge and jury will be the regulatory authorities who grant approval, the patent office, and whoever else, not you.
You don't decide what needs to be shown, what does not, what you would like FUM to do or not.
You are insignificant in all matters FUM and this board.
So if they claim it works, and have in vitro data to show how it does, and don't need to do anything else (in vivo or other comparison) to get to market, then so be it. Who are you to make all these claims, a nobody that cannot do anything about it but cry on a BB to mislead folks.
As Furtura said "Futura conducted further research and analysis in 2020 which demonstrated the mode of action for MED3000 as shown in the graph. MED3000 generates a rapid cooling and recovery warming action, promoting a sensory stimulation of the nerves on the glans ***** leading to fast smooth muscle relaxation, tumescence and erection."
Why did you manipulate the text from the ASA Felxiseq case to make it look like in your post all the wording came from a ruling on Med30000. By replacing the word Flexiseq with Med3000? Care to tell the board why you did that?
ANSWERS ON A POSTCARD
Mine - Deliberate Misleading and manipulation of this board and posts and references to suit his own agenda.
"False Its still not known what caused the effects in FM57" - so what else could it have been? You suggesting 15 seconds massaging and Psychological effect caused it. In Mild/moderate/Sever ED sufferers? And don't say look at the I/E criteria.
So nothing else was given, they magically get erections because of massaging or phycological, in over 60% .
Can't be GTN as Dermasys / placebo showed it had similar changes to the same outcome as MED2005 (which includes GTN)
I suggest you take your science to FUM and the two articles, and report back.
As Furtura said "Futura conducted further research and analysis in 2020 which demonstrated the mode of action for MED3000 as shown in the graph. MED3000 generates a rapid cooling and recovery warming action, promoting a sensory stimulation of the nerves on the glans ***** leading to fast smooth muscle relaxation, tumescence and erection."
Because it was shown it was Dermasys (the placebo) which caused the erections
OMG.
Hence Med2005 without GTN became Med3000 / Eroxxon / Dermsys which showed in FM57 as the reason for the erections.
YOU CANNOT STOP IT FROM WORKING.
IT WORKS AND IS PROVEN
Why did you manipulate the text from the ASA Felxiseq case to make it look like in your post all the wording came from a ruling on Med30000. By replacing the word Flexiseq with Med3000? Care to tell the board why you did that?
Explain please
He also said:
"The efficacy of Eroxon® is remarkable and approaches the efficacy of current first line therapy but with significantly lower adverse events. With topical application, it will be of particular appeal to mild to moderate ED patients who want a fast onset of action. Lack of drug interactions with prescription products will enable the product to be used with other medications such as nitrates and other cardiovascular drugs. It can also be used in conjunction with other ED products to improve overall efficacy to patients. As such the product will be of great interest to the medical community"
PROFESSOR DAVID RALPH
Consultant Urologist St. Peter’s Andrology Centre & Institute of Urology, UCLH, London
Past President of the European Society of Sexual Medicine
As did
"In my humble opinion and as an expert in the field of erectile dysfunction management, I am very supportive of Eroxon® and do believe that it offers an important and valid addition to the armamentarium of treatments we can offer our patients for erectile dysfunction."
PROFESSOR ARTHUR BURNETT
Johns Hopkins University School of Medicine, Baltimore, US
MD, MBA, FACS, Patrick C Walsh Distinguished Professor of Urology
Past President of the Sexual Medicine Society of North America
When we quote it, your comeback is they are paid (as per previous posts), but when you quote Dr Ralphs, it is fine. Hypocritical.
Where is this published paper that you say " Quite the contrary according to David Ralph in the previous Phase 2 study who said in a the published peer reviewed paper on that study that there was no difference in onset because the products were massaged causing stimulation.!
LIAMBOOTH making the same rubbish claims and posts again and again will not make them magically come true.
Everyone on here that reads this BB, knows that you have been shown to have no credibility in your posts and what you are saying, as shown again and again to be discredited, misleading and fake in everything you do on this BB.
You make outlandish posts like your last one when the fact is MED3000 is Unique and not like anything else out there, and will be first to OTC market, access to 3.6bliiion market and has commercial deals in place and regulatory approvals in place or pending.
"MED3000 works through a unique evaporative mode of action. MED3000’s combination of volatile components creates a novel action that stimulates nerve sensors in the highly innervated glans ***** by a cooling and recovery warming effect, rapidly leading to smooth muscle relaxation, tumescence and erection as shown on the diagram below.
The glans ***** is very highly innervated and there are sensors which are reactive to a range of physical sensations, including touch, pressure and temperature. Futura conducted further research and analysis in 2020 which demonstrated the mode of action for MED3000 as shown in the graph. MED3000 generates a rapid cooling and recovery warming action, promoting a sensory stimulation of the nerves on the glans ***** leading to fast smooth muscle relaxation, tumescence and erection"
I think LB and friends cannot handle the fact that there is nothing he/they can do now:
- To stop Eroxon going to market.
- To stop all the commercial deals
- To stop Eroxon being first to OTC market
- To stop the writing on the box and the advertising
- To make the product stop working
- Stop us all from know how much of a fake he/they are
- Stop us from knowing he has no credibility and he is misleading this BB totally
- Stop regulatory approval globally.
- Stop all future deals
- To stop people from using it
- To stop Eroxon gving millions of ED sufferers erections
HE CANNOT STOP ANYTHIN NOW
He is frustrated he cannot make Eroxon go away, so is making up all his theories, and accusations up like ASA will have a case again MED3000 by manipulating the text from Flexiseq case to look like its a case against Med3000
Accusations like they circumvented the CE mark, which they never did, they got the CE mark and showed the data / did the science first.
Lots and lots of made up stuff from LB
He / They cannot stop Eroxon going to market and being first to the OTC market. Hahahaha.
You been disproven on this point before - see the board history. Repeating is not going to make it more valid.
Plus everyone should know in context, ASA jurisdiction is UK, what you going to do in every other country? cite the same posts and irrelevant and totally unconnected ASA v Flexiseq. and manipulate the text from that ruling to imply it to MED3000
Why did you manipulate the text from the ASA Felxiseq case to make it look like in your post all the wording came from a ruling on Med30000. By replacing the word Flexiseq with Med3000? Care to tell the board why you did that?
But IMO the messages/ this BB has to be clear on here for anyone looking, and I don' wan t the repeated misleading and misdirected posts from Liambooth to be the point of reference, without the counter argument, repetitive as allt his / my posts are.
Good night all decent folks out there with morals and ethics.
MED3000 was approved in April 2021 as a medical device in the EU and becomes the first clinically proven, pan-European OTC topical treatment for erectile dysfunction available without a doctor’s prescription.
No one in their right mind (doctors, pharmacists, pharmacy staff, friends, colleagues) are going to say take KY, Vicks, Other lubricants etc or this placebo pill (they are all not clinically/efficaciously proven for ED), when there is a clinical proven efficacious Med3000 (Eroxon) approved by regulatory authorities and available OTC.
First to the OTC market. MED3000 is a unique and highly differentiated easy to use topical gel for erectile dysfunction which has Phase 3 clinical data demonstrating highly statistically significant improvement across all ED patient severities and recently approved in the EU as a medical device with potential peak sales of US$1 billion
- MED3000 is supported by efficacy and safety data from a range of studies including the completed Phase 3 study.
- MED3000 achieved all co-primary clinical endpoints against before treatment (baseline) with highly statistically significant p values of less than 0.001 in all instances.
- MED3000 also showed statistical improvements on both GAQ (Global Assessment Questionnaire) and SEAR (Self-Esteem And Relationship Questionnaire) secondary endpoints.
- MED3000 also showed meaningful clinical differences across all ED patient groups, mild, moderate and severe, which is a key evaluation criteria for regulators.
- MED3000 begins to work immediately in some patients, with 60% of patients seeing onset of their erection within 10 minutes of application.
- MED3000 had an excellent safety profile with very low incidence of adverse events in males and female partners.
- There was a high degree of consistency in the data sets across the different countries and between the two CROs running the study.
- Results demonstrated that MED3000 has the potential to be a highly effective, clinically proven, topical treatment for erectile dysfunction.
- Results enabled Futura to receive approval for MED3000 in the EU as a medical device and will enable Futura to pursue the medical device regulatory pathway for MED3000 in the US.
For full and more comprehensive information please see here.
https://www.futuramedical.com/what-we-do/med3000/med3000-clinical-programme/
PS LIAMBOOTH, why did you manipulate the text from the ASA Felxiseq case to make it look like in your post all the wording came from a ruling on Med30000. By replacing the word Flexiseq with Med3000? Care to tell the board why you did that?
Explain please.
You are voiding this question as multiple member have requested you answer this.
You denied several requests to explain this, meaning you deliberately manipulated the text to mislead this BB
We know you been doing that for ages,. What you say is not credible and hasn't been IMO for a long time.
You had the chance, but I will keep posting, may be like my next post, which for me is not great personally, but no way as low as you have sunken and been shown to be a fake LTH and mislead people and investors.
Hey okay, chill out a little:
As you say, "So if they “have moved on” then why don’t the just repeat the doppler studies on MED3000 users and prove it?"
"And why in the patent application do they only talk about demonstrating in vitro cooling? Why dont they just definitively demonstrate the supposed in vivo cooling/rewarming effect which supposedly increases blood flow with 2021 Doppler studies?
Simples, because they don't need to, to get to market
Any other questions?